We and others have demonstrated that, clinically, elevated SR-B1 expression has been found to be associated with high Gleason-grade primary PCa wherein high expression was correlated with decreased disease-specific survival of PCa patients [90,250]. The gene discussed is SCARB1; the disease is posterior cortical atrophy.